Search results
Results from the WOW.Com Content Network
Genentech, Inc. is an American biotechnology corporation headquartered in South San Francisco, California, wholly owned by the Swiss multinational pharmaceutical company, the Roche Group. It became an independent subsidiary of Roche in 2009. Genentech Research and Early Development operates as an independent center within Roche. [6]
Efalizumab (brand name Raptiva, Genentech, Merck Serono) is a formerly available medication designed to treat autoimmune diseases, originally marketed to treat psoriasis. As implied by the suffix -zumab , it is a recombinant humanized monoclonal antibody administered once weekly by subcutaneous injection .
Printable version; In other projects Wikidata item; Appearance. ... Pages in category "Drugs developed by Genentech" The following 102 pages are in this category, out ...
Genentech pioneered the use of recombinant human growth hormone for human therapy, which was approved by the FDA in 1985. [citation needed] Prior to its production by recombinant DNA technology, growth hormone used to treat deficiencies was extracted from the pituitary glands of cadavers. Attempts to create a wholly synthetic HGH failed.
The first company to focus on genetic engineering, Genentech, was founded in 1976 and started the production of human proteins. Genetically engineered human insulin was produced in 1978 and insulin-producing bacteria were commercialised in 1982. Genetically modified food has been sold since 1994, with the release of the Flavr Savr tomato. The ...
While there was still plenty of work to be done on the human insulin synthesis, the new stream of revenues and the significant amount of media coverage meant that Genentech could pursue other research projects. [6] By 1979, Genentech had projects on interferons, animal growth hormones, hepatitis B vaccines, and the hormone thymosin. [6]
David V. Goeddel (born 1951) is an American molecular biologist who, employed at the time by Genentech, successfully used genetic engineering to coax bacteria into creating synthetic human insulin, human growth hormone, and human tissue plasminogen activator (tPA) for use in therapeutic medicine.
Main page; Contents; Current events; Random article; About Wikipedia; Contact us; Pages for logged out editors learn more